YAZ

This brand name is authorized in Austria, Brazil, Canada, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain.

Active ingredients

The drug YAZ contains a combination of these active pharmaceutical ingredients (APIs):

1	Drospirenone UNII N295J34A25 - DROSPIRENONE
	Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone.
	Read more about Drospirenone
2	17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL
	Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about 17 alpha-Ethinylestradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AA12	Drospirenone and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538912050016313, 538912120021103, 538917100027503, 538917100027603, 538917100027703, 538917100027803
CA	Health Products and Food Branch	02321157
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28242-08-07
EE	Ravimiamet	1316090, 1316102, 1316113, 1476840
ES	Centro de información online de medicamentos de la AEMPS	70093
FI	Lääkealan turvallisuus- ja kehittämiskeskus	136584, 136595, 136607
FR	Base de données publique des médicaments	61727306
HK	Department of Health Drug Office	56563
HR	Agencija za lijekove i medicinske proizvode	HR-H-604240169
IE	Health Products Regulatory Authority	53035
IL	מִשְׂרַד הַבְּרִיאוּת	6485, 6486
JP	医薬品医療機器総合機構	2482011F1020, 2482011F2027
LT	Valstybinė vaistų kontrolės tarnyba	1027077, 1033484, 1033485, 1054467, 1090981
MT	Medicines Authority	MA639/00601, PI1438/06801A, PI1438/06801B
NL	Z-Index G-Standaard, PRK	105694
NZ	Medicines and Medical Devices Safety Authority	13453
PL	Rejestru Produktów Leczniczych	100184244, 100374140, 100384606, 100392250, 100458291, 100460373
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64054001, W64054002, W64054003
SG	Health Sciences Authority	13584P
ZA	Health Products Regulatory Authority	41/21.8.2/0842